Search research articles

ABOUT JoVE

Overview Leadership Blog JoVE Help Center

AUTHORS

Publishing Process Editorial Board Scope & Policies Peer Review FAQ Submit

LIBRARIANS

Testimonials Subscriptions Access Resources Library Advisory Board FAQ

RESEARCH

JoVE Journal Methods Collections JoVE Encyclopedia of Experiments Archive

EDUCATION

JoVE Core JoVE Business JoVE Science Education JoVE Lab Manual Faculty Resource Center Faculty Site

Terms & Conditions of Use

Search research articles

Related Experiment Videos

CD95 ligand expression on alpha cells: protection or killing?

G Ruberti¹, A Signore

¹Department of Immunobiology, Institute of Cell Biology, National Research Council, Rome, Italy.

Diabetes/Metabolism Reviews

|July 29, 1998

Summary

No abstract available in PubMed .

Related Experiment Videos

Related Concept Videos

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by

Same author

[<sup>18</sup>F]FDG-PET/CT and long-term responses to everolimus in advanced neuroendocrine neoplasia.

Journal of endocrinological investigation·2020

Same author

Labelling and Clinical Performance of Human Leukocytes Labelled with <sup>99m</sup>Tc-HMPAO Using Leukokit® with Gelofusine versus Leukokit® with HES as Sedimentation Agent.

Contrast media & molecular imaging·2019

Same author

Study of Binding Kinetics and Specificity of <sup>99m</sup>Tc-SSS-Complex and <sup>99m</sup>Tc-HMPAO to Blood Cells.

Contrast media & molecular imaging·2018

Same author

Clinical indications, image acquisition and data interpretation for white blood cells and anti-granulocyte monoclonal antibody scintigraphy: an EANM procedural guideline.

European journal of nuclear medicine and molecular imaging·2018

Same author

Combined PET/MRI: from Status Quo to Status Go. Summary Report of the Fifth International Workshop on PET/MR Imaging; February 15-19, 2016; Tübingen, Germany.

Molecular imaging and biology·2016

Same author

Somatostatin receptor scintigraphy in patients with rheumatoid arthritis and secondary Sjögren's syndrome treated with Infliximab: a pilot study.

EJNMMI research·2016